company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,130344000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,435000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,130779000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28184000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28184000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,102595000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12662000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,21657000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32371000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66690000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35905000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5175000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,920000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4290000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,31615000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7839000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23776000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23776000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23776000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57642460.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.41
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68221269.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58000000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 11:05:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.41
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,143088000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,446000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,143534000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30771000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30771000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,112763000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12857000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18883000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35527000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67267000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45496000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5293000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1147000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-24000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4170000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,41326000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15947000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25379000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,25379000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,25379000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57842403.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68534597.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.42
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57700000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2009.0,Q3,2009-07-01,2009-09-30,2010-10-29 13:13:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,143629000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,435000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,144064000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31759000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31759000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,112305000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34583000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38882000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1508000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74973000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,37332000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5386000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1270000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1193000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5309000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32023000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11591000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20432000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20432000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20432000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58217628.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68928596.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58400000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 10:10:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,168103000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,435000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,168538000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36419000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36419000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,132119000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37049000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40147000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1187000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78383000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53736000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5459000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1317000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1250000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5392000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48344000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20229000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28115000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,28115000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,28115000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58670728.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69302106.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58600000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 13:53:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.48
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,160495000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1556000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,162051000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,37000000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,37000000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,125051000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34871000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36955000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1094000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72920000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,52131000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5534000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1068000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3788000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-678000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51453000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20225000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31228000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31228000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31228000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59047880.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69780060.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58900000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q3,2010-07-01,2010-09-30,2011-11-02 13:48:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,161190000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,615000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,161805000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,35587000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35587000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,126218000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36840000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41870000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1108000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79818000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,46400000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9201000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1045000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15755000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23911000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22489000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7939000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14550000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14550000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14550000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58795467.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62659632.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.26
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59000000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,162016000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,515000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,162531000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36577000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36577000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,125954000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40164000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40416000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1098000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81678000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44276000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7953000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,773000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,373000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6807000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,37469000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14884000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22585000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22585000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22585000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59362021.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79533776.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59400000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 14:22:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,176322000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,516000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,176838000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,38976000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,38976000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,137862000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38341000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41871000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,81816000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,162028000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24166000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7754000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,631000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,162000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6961000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31127000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10512000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20615000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20615000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20615000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60517553.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60517553.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60600000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 09:06:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,199231000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2467000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,201698000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,48380000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,48380000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,153318000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35949000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46171000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2069000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,84189000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,69129000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7878000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,598000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,467000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6813000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,62316000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,38081000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24235000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24235000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24235000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61238131.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82528893.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.33
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60600000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 09:04:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,207181000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,5724000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,212905000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,48931000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,48931000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,163974000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48774000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,56075000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-84983000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9279000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,91537000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,120682000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43292000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7830000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,668000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7161000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36131000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29313000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6818000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6818000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6818000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60839128.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62937141.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61200000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,210467000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1225000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,211692000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,53952000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,53952000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,157740000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43780000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51172000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2829000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,97781000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,59959000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9007000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,674000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-180000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8513000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51446000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18652000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32794000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32794000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32794000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63001379.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84386002.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63100000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 08:48:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,229914000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,653000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,230567000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,58891000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,58891000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,171676000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40255000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,67206000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2694000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,110155000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,61521000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8902000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,742000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3113000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11273000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,50248000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7125000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43123000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43123000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43123000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63498953.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.68
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,81166329.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63400000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:41:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.68
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,237528000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,653000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,238181000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,55740000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,55740000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,182441000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40420000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,70197000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1473000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,112090000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,70351000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7629000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,817000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3359000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10171000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,60180000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19859000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40321000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,40321000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,40321000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64048673.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82856912.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64000000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 09:25:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,245165000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,754000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,245919000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,61474000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,61474000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,184445000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47333000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,89154000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-6996000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,38700000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-29021000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,139170000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45275000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7453000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,843000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-943000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7553000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,37722000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-115000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37837000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37837000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37837000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63766209.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,81444658.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63700000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,229275000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,654000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,229929000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,55675000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,55675000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,174254000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48201000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,114209000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2053000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,164463000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9791000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7184000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,742000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,240000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6202000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3589000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2499000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6088000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6088000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6088000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64935601.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67034457.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67600000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 08:29:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,258127000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,652000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,258779000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,63041000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,63041000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,195738000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49889000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,115190000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2586000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,167665000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28073000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7250000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,718000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-146000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6678000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21395000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6153000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15242000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15242000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15242000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65558376.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67731976.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66300000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:06:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,260338000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,5655000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,265993000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,60989000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,60989000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,205004000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,73855000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,123423000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1029000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2641000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,200948000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4056000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8924000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,624000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34871000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-43171000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39115000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5220000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33895000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33895000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33895000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67841665.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67841665.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67800000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 09:02:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,296980000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2761000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,299741000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,80605000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,80605000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,219136000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,85995000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,124918000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,55300000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,23290000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-54857000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,234646000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15510000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14244000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,354000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-113000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14003000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29513000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-23507000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6006000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6006000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6006000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68160798.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68160798.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68800000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,257485000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3748000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,261233000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,73541000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,73541000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,187692000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,69662000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,120603000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2439000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-33318000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,159386000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28306000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14395000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,377000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-69000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14087000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14219000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10014000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24233000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24233000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24233000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74934776.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85596348.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75700000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q1,2014-01-01,2014-03-31,2014-05-02 08:29:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,282744000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,11654000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,294398000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,88613000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,88613000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,205785000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,80057000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,104862000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3469000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-24774000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,163614000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42171000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14508000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,317000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,56000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14135000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28036000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4008000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24028000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24028000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24028000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75421354.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86108783.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75100000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:06:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,308502000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,653000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,309155000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,94959000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,94959000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,214196000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,77791000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,66032000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,340000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2224000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,146387000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,67809000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14664000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,276000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,357000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14031000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,53778000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,30949000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22829000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22829000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22829000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75834443.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85995727.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76100000.0
Cubist Pharmaceuticals Inc ,CBST,,0000912183,2014.0,Q3,2014-07-01,2014-09-30,2014-11-07 09:02:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
